Stem cells in chemical carcinogenesis.
Arch. Toxicol.
2010;84;3
Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling.
Gut
2010;59;2
Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis.
Semin. Liver Dis.
2010;30;1
Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours.
Comp Hepatol
2010;9;1

Rescue of a marginal liver graft by sequential treatment with molecular adsorbent recirculating system and transjugular intrahepatic portosystemic shunt: a case report.
Transplant. Proc.
2009;41;8
Quantitation of replication of the HCV genome in human livers with end-stage cirrhosis by strand-specific real-time RT-PCR assays: methods and clinical relevance.
J. Med. Virol.
2009;81;9
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
J. Exp. Med.
2009;206;8

Hepatosplenic gammadelta T-cell lymphoma after liver transplantation: report of the first 2 cases and review of the literature.
Liver Transpl.
2009;15;7
A low frequency of lymph node metastasis in clear-cell renal cell carcinoma is related to low lymphangiogenic activity.
BJU Int.
2009;103;12

Central role of c-Myc during malignant conversion in human hepatocarcinogenesis.
Cancer Res.
2009;69;7

Where is TRPV1 expressed in the bladder, do we see the real channel?
Naunyn Schmiedebergs Arch. Pharmacol.
2009;379;4

Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside?
Gut
2009;58;4
Different angiogenic potential in low and high grade sporadic clear cell renal cell carcinoma is not related to alterations in the von Hippel-Lindau gene.
Cellular oncology : the official journal of the International Society for Cellular Oncology
2009;31;5
Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis.
J. Hepatol.
2009;50;1

Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin.
Liver Int.
2008;28;10

Relationships among stellate cell activation, progenitor cells, and hepatic regeneration.
Clin Liver Dis
2008;12;4
The extent of vacuolation in non-heart-beating porcine donor liver grafts prior to transplantation predicts their viability.
Liver Transpl.
2008;14;9

Cholestatic liver disease in long-term infantile nephropathic cystinosis.
J. Gastroenterol. Hepatol.
2008;23;8 Pt 2

Multidrug resistance-associated proteins are crucial for the viability of activated rat hepatic stellate cells.
Hepatology
2008;48;2
IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver.
Proc. Natl. Acad. Sci. U.S.A.
2008;105;28
The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.
J. Hepatol.
2008;49;1
Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis.
Gut
2008;57;5
Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.
Hepatology
2008;47;5
Squamous cell carcinoma antigen in human liver carcinogenesis.
J. Clin. Pathol.
2008;61;4

Porphyria cutanea tarda and liver disease. A retrospective analysis of 17 cases from a single centre and review of the literature.
Acta Gastroenterol. Belg.
2008;71;2
Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.
Clin. Cancer Res.
2008;14;7
Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo.
Gut
2008;57;3

Lack of cilia and differentiation defects in the liver of human foetuses with the Meckel syndrome.
Liver Int.
2008;28;3

Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development.
Hepatology
2008;47;2
Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding.
J. Clin. Invest.
2007;117;11
Influence of the glycosaminoglycan layer on the permeation of hypericin in rat bladders in vivo.
BJU Int.
2007;100;5
Hemodynamic, biochemical, and morphological characteristics during preservation of normal porcine livers by hypothermic machine perfusion.
Transplant. Proc.
2007;39;8

Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
Gastroenterology
2007;133;4
Contribution of interleukin-6/gp 130 signaling in hepatocytes to the inflammatory response in mice infected with Streptococcus pyogenes.
J. Infect. Dis.
2007;196;5
High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
Br. J. Cancer
2007;96;12
Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
Gastroenterology
2007;132;7
The RANTES -28 g polymorphism is associated with primary sclerosing cholangitis.
Gut
2007;56;6
MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure.
Liver Int.
2007;27;3
Human hepatic progenitor cells express vasoactive intestinal peptide receptor type 2 and receive nerve endings.
Liver Int.
2007;27;3

Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update.
J. Hepatol.
2007;46;3
Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.
Cancer Cell
2007;11;2
Both Ca2+ -dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine.
Am. J. Physiol. Gastrointest. Liver Physiol.
2007;292;2

Comparing results after surgery in patients with clinical unilateral T3a prostate cancer treated with or without neoadjuvant androgen-deprivation therapy.
BJU Int.
2007;99;2
Transrectal ultrasound in the staging of clinical T3a prostate cancer.
Eur J Surg Oncol
2007;33;1
Major HGF-mediated regenerative pathways are similarly affected in human and canine cirrhosis.
Comp Hepatol
2007;6
Liver regeneration in acute severe liver impairment: a clinicopathological correlation study.
Liver Int.
2006;26;10
Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
Am. J. Surg. Pathol.
2006;30;11

Molecular diagnostic approach to liver tissue as an ancillary tool for liver histopathology.
Semin. Liver Dis.
2006;26;4


Detection of clinical unilateral T3a prostate cancer - by digital rectal examination or transrectal ultrasonography?
BJU Int.
2006;98;5
Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers.
Am. J. Gastroenterol.
2006;101;10

Metanephric adenoma during pregnancy: clinical presentation, histology, and cytogenetics.
Hum. Pathol.
2006;37;9
The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.
Histopathology
2006;49;2

Transforming growth factor beta-1 signalling in canine hepatic diseases: new models for human fibrotic liver pathologies.
Liver Int.
2006;26;6

Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review.
Ann. Oncol.
2006;17;8

Different types of liver progenitor cells and their niches.
J. Hepatol.
2006;45;1

Liver stem cells and their implication in hepatocellular and cholangiocarcinoma.
Oncogene
2006;25;27
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases.
Hepatology
2006;43;5

CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis.
Inflamm. Bowel Dis.
2006;12;4
A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.
Eur. J. Clin. Invest.
2006;36;4


A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.
Nat. Med.
2006;12;4
Management of small focal liver lesions in a cirrhotic liver: discussion.
Acta Gastroenterol. Belg.
2006;69;2

Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus.
J. Virol.
2006;80;6
Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin.
Int. J. Oncol.
2006;28;3

The impact of aggregation on the biodistribution of hypericin.
Int. J. Oncol.
2006;28;3
Morphological characterisation of portal myofibroblasts and hepatic stellate cells in the normal dog liver.
Comp Hepatol
2006;5
A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis.
Hepatology
2005;42;6
Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
Gastroenterology
2005;129;5

Nodular regenerative hyperplasia, portal vein thrombosis, and avascular hip necrosis due to hyperhomocysteinaemia.
Gut
2005;54;7

Influence of TIPS on development of hepatocellular carcinoma in cirrhosis.
Hepatology
2005;42;1
Cancer cell dissemination during curative surgery for colorectal liver metastases.
Eur J Surg Oncol
2005;31;5



Peripheral bile duct paucity and cholestasis in the liver of a patient with Alagille syndrome: further evidence supporting a lack of postnatal bile duct branching and elongation.
Am. J. Surg. Pathol.
2005;29;6
High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB.
J. Pathol.
2005;206;2
Enhancing the photodynamic effect of hypericin in tumour spheroids by fractionated light delivery in combination with hyperoxygenation.
Int. J. Oncol.
2005;26;6
Livers from non-heart-beating donors tolerate short periods of warm ischemia.
Transplantation
2005;79;9

Elucidation of the tumoritropic principle of hypericin.
Br. J. Cancer
2005;92;8
Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury.
J. Clin. Invest.
2005;115;4
The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
J. Clin. Invest.
2005;115;4
Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.
Hepatology
2005;41;4

Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages.
Blood
2005;105;4

Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection.
Gastroenterology
2005;128;2

Preneoplastic lesions in human hepatocarcinogenesis.
Liver Int.
2005;25;1
In vivo accumulation of different hypericin ion pairs in the urothelium of the rat bladder.
BJU Int.
2005;95;3

Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin.
Gastroenterology
2005;128;1

Early hepatocellular carcinoma and dysplastic nodules.
Semin. Liver Dis.
2005;25;2
Liver fatty acid-binding protein: an early and sensitive plasma marker of hepatocellular damage and a reliable predictor of graft viability after liver transplantation from non-heart-beating donors.
Transplant. Proc.
2005;37;1
Does ex vivo vascular resistance reflect viability of non-heart-beating donor livers?
Transplant. Proc.
2005;37;1

Serum markers detect the presence of liver fibrosis: a cohort study.
Gastroenterology
2004;127;6
Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.
J. Natl. Cancer Inst.
2004;96;21

Alpha-1 adrenergic receptor agonists modulate ductal secretion of BDL rats via Ca(2+)- and PKC-dependent stimulation of cAMP.
Hepatology
2004;40;5

Combined 'en bloc' liver and pancreas transplantation in patients with liver disease and type 1 diabetes mellitus.
Am. J. Transplant.
2004;4;11
Halofuginone can worsen liver fibrosis in bile duct obstructed rats.
Liver Int.
2004;24;5
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.
Hepatology
2004;40;3

Stellate-type scirrhous dysplastic nodules in liver cirrhosis: identical to focal nodular hyperplasia-like nodules?
J. Gastroenterol. Hepatol.
2004;19;8
Expression of hepatitis C virus core protein impairs DNA repair in human hepatoma cells.
Cancer Lett.
2004;209;2


Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.
Gastroenterology
2004;126;7

Cirrhosis reversal: a duel between dogma and myth.
J. Hepatol.
2004;40;5

Hepatic fibrogenesis requires sympathetic neurotransmitters.
Gut
2004;53;3

Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease.
Hepatology
2004;39;2
Whole bladder wall photodynamic therapy of transitional cell carcinoma rat bladder tumors using intravesically administered hypericin.
Int. J. Cancer
2003;107;3


A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C.
Hepatology
2003;38;5
Hepatic artery malformations associated with a primary defect in intrahepatic bile duct development.
J. Hepatol.
2003;39;5

Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease.
Am. J. Pathol.
2003;163;4

Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury.
Hepatology
2003;38;3

Complex genomic rearrangement of ALK loci associated with integrated human Epstein-Barr virus in a post-transplant myogenic liver tumor.
Am. J. Pathol.
2003;163;3


Progenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus.
J. Hepatol.
2003;39;3

Reversal of cirrhosis: evidence-based medicine?
Gastroenterology
2003;125;2
Steroid-free immunosuppression during and after liver transplantation--a 3-yr follow-up report.
Clin Transplant
2003;17;3
Aggregated colon cancer cells have a higher metastatic efficiency in the liver compared with nonaggregated cells: an experimental study.
J. Surg. Res.
2003;112;1

Stages of normal and aberrant intrahepatic bile duct development in a mixed hepatoblastoma.
Histopathology
2003;42;6

Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity.
Am. J. Physiol. Gastrointest. Liver Physiol.
2003;284;4
Microscopic quantification of hypercin fluorescence in an orthotopic rat bladder tumor model after intravesical instillation.
Int. J. Oncol.
2003;22;4
Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes.
Gastroenterology
2003;124;3
Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection.
J. Hepatol.
2003;38;2
Liver pathology and hepatocarcinogenesis in a long-term mouse model of erythropoietic protoporphyria.
J. Pathol.
2003;199;2

Histopathology of portal hypertension: a practical guideline.
Histopathology
2003;42;1

Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research.
J. Hepatol.
2002;37;4
Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations.
Liver Transpl.
2002;8;9
In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats.
Gut
2002;51;3
Ultrastructural visualization of hepatitis C virus components in human and primate liver biopsies.
J. Hepatol.
2002;37;3
The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor type 3.
Am. J. Pathol.
2002;161;2
The correlation between portal myofibroblasts and development of intrahepatic bile ducts and arterial branches in human liver.
Liver
2002;22;3

The role of immunohistochemistry in diagnosis.
Clin Liver Dis
2002;6;2
Hypericin-based fluorescence diagnosis of bladder carcinoma.
BJU Int.
2002;89;7
Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.
Int. J. Cancer
2002;98;2


Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature.
Transpl. Int.
2002;15;2-3
Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer.
Int. J. Cancer
2002;98;1
Immunological and virological effects of ribavirin in hepatitis C after liver transplantation.
Transplantation
2002;73;3
Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers.
J. Hepatol.
2002;36;2
Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy.
Int. J. Cancer
2002;97;2


Why are patients with liver disease jaundiced? ATP-binding cassette transporter expression in human liver disease.
J. Hepatol.
2001;35;6
Hepatic progenitor cells in hepatocellular adenomas.
Am. J. Surg. Pathol.
2001;25;11
Alpha B-crystallin expression in human and rat hepatic stellate cells.
J. Hepatol.
2001;35;2
Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model.
Int. J. Cancer
2001;93;2
Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis.
Histopathology
2001;39;1
Liver transplantation for polycystic liver disease.
Liver Transpl.
2001;7;3

Surgical strategy in liver transplantation for polycystic liver disease.
Transplant. Proc.
2001;33;1-2
Standard cyclosporine A-based versus completely steroid-free FK506-based immunosuppression after liver transplantation.
Transplant. Proc.
2001;33;1-2
Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors.
Hepatology
2001;33;1

Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: can 'progenitor cells' migrate?
J. Pathol.
2000;192;3

Carcinoma of the kidney, testis, and rare urologic malignancies.
Am. J. Clin. Oncol.
2000;23;5
The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells.
J. Hepatol.
2000;33;1
Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoural cells?
J. Pathol.
2000;191;2

Malignant angiomyolipoma of the liver: a hitherto unreported variant.
Histopathology
2000;36;5
Improvement of chronic active hepatitis C in chronically infected chimpanzees after therapeutic vaccination with the HCV E1 protein.
Acta Gastroenterol. Belg.
2000;63;2
Influence of the administration of human annexin V on in vitro binding of small hepatitis B surface antigen to human and to rat hepatocytes and on in vitro hepatitis B virus infection.
J. Viral Hepat.
2000;7;2
Synaptophysin: A novel marker for human and rat hepatic stellate cells.
Am. J. Pathol.
1999;155;6
Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells.
Am. J. Pathol.
1999;155;5

Involvement of 12q12-13 is a nonrandom chromosome change in renal oncocytoma.
Genes Chromosomes Cancer
1999;24;1
Hepatitis B virus infection in microcarrier-attached immortalized human hepatocytes cultured in molecularporous membrane bags: a model for long-term episomal replication of HBV.
J. Viral Hepat.
1998;5;6

Ductular reaction and its diagnostic significance.
Semin Diagn Pathol
1998;15;4
Expression of cytokeratin 20 in developing rat liver and in experimental models of ductular and oval cell proliferation.
J. Hepatol.
1998;29;4
Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man.
J. Hepatol.
1998;29;3

Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour?
Liver
1998;18;4
NO synthase in the liver: prospects of in vivo gene transfer.
Digestion
1998;59 Suppl 2
Heparan sulphate proteoglycan expression in human primary liver tumours.
J. Pathol.
1998;185;3

Nimesulide-induced acute hepatitis: evidence from six cases.
J. Hepatol.
1998;29;1
Histopathology of vanishing bile duct diseases.
Adv Clin Path
1998;2;2

Parathyroid-hormone-related peptides. A new class of multifunctional proteins.
Am. J. Pathol.
1997;150;3
Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
Hepatology
1996;24;3
'Undifferentiated progenitor cells' in focal nodular hyperplasia of the liver.
Histopathology
1996;28;4
Parathyroid hormone-related peptide is expressed and rapidly inducible in human liver cell cultures that have a bile duct phenotype.
J. Hepatol.
1995;23;2

Ductular reaction in the liver.
Pathol. Res. Pract.
1995;191;6
Heparan sulfate proteoglycan expression in normal human liver.
Hepatology
1995;21;4
Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndrome.
J. Med. Virol.
1994;44;3

Polyarteritis nodosa type vasculitis in a patient with familial Mediterranean fever treated with cyclosporin A.
Transpl. Int.
1994;7;4
Parathyroid hormone-related peptide expression in primary and metastatic liver tumours.
Histopathology
1993;23;6
Transient expression of tenascin in experimentally induced cholestatic fibrosis in rat liver: an immunohistochemical study.
J. Hepatol.
1993;19;3
Reactive human bile ductules express parathyroid hormone-related peptide.
Histopathology
1993;23;1
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.